GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $13,891,000 | +25.8% | 951,437 | +22.4% | 0.06% | +9.4% |
Q3 2020 | $11,041,000 | -23.1% | 777,570 | -20.3% | 0.05% | -32.1% |
Q2 2020 | $14,359,000 | +51.9% | 976,122 | -57.4% | 0.08% | +27.9% |
Q1 2020 | $9,450,000 | -13.5% | 2,293,136 | +0.9% | 0.06% | -6.2% |
Q4 2019 | $10,928,000 | -23.1% | 2,271,836 | -3.1% | 0.06% | -15.6% |
Q3 2019 | $14,208,000 | -16.2% | 2,344,647 | -10.2% | 0.08% | -23.8% |
Q2 2019 | $16,950,000 | -5.9% | 2,611,855 | +2.8% | 0.10% | -15.8% |
Q1 2019 | $18,009,000 | +60.1% | 2,540,041 | +9.7% | 0.12% | +39.5% |
Q4 2018 | $11,250,000 | -34.5% | 2,314,931 | -0.9% | 0.09% | -30.6% |
Q3 2018 | $17,179,000 | +16.3% | 2,337,132 | +0.9% | 0.12% | +6.9% |
Q2 2018 | $14,775,000 | +14.5% | 2,315,747 | -2.4% | 0.12% | +7.4% |
Q1 2018 | $12,909,000 | +31.4% | 2,373,298 | +0.7% | 0.11% | +33.3% |
Q4 2017 | $9,826,000 | -56.8% | 2,355,942 | -0.2% | 0.08% | -58.2% |
Q3 2017 | $22,737,000 | -18.6% | 2,360,984 | 0.0% | 0.19% | -22.4% |
Q2 2017 | $27,930,000 | +4.0% | 2,360,984 | +12.7% | 0.25% | -2.7% |
Q1 2017 | $26,846,000 | +4.7% | 2,094,015 | 0.0% | 0.26% | -7.6% |
Q4 2016 | $25,631,000 | +4.7% | 2,094,015 | +0.9% | 0.28% | -2.1% |
Q3 2016 | $24,477,000 | +5973.7% | 2,074,347 | +4380.1% | 0.28% | +5580.0% |
Q2 2016 | $403,000 | +70.8% | 46,301 | +3.5% | 0.01% | +400.0% |
Q1 2016 | $236,000 | -31.8% | 44,721 | 0.0% | 0.00% | -75.0% |
Q4 2015 | $346,000 | +8.5% | 44,721 | +10.3% | 0.00% | 0.0% |
Q3 2015 | $319,000 | -6.2% | 40,533 | +8.0% | 0.00% | -20.0% |
Q2 2015 | $340,000 | -10.5% | 37,533 | +28.1% | 0.01% | -16.7% |
Q1 2015 | $380,000 | +55.1% | 29,296 | +62.8% | 0.01% | +50.0% |
Q4 2014 | $245,000 | +129.0% | 17,998 | +51.2% | 0.00% | +100.0% |
Q3 2014 | $107,000 | -33.5% | 11,905 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $161,000 | +36.4% | 11,905 | 0.0% | 0.00% | +50.0% |
Q1 2014 | $118,000 | -25.3% | 11,905 | 0.0% | 0.00% | -33.3% |
Q4 2013 | $158,000 | +9.0% | 11,905 | 0.0% | 0.00% | -25.0% |
Q3 2013 | $145,000 | +17.9% | 11,905 | 0.0% | 0.00% | +33.3% |
Q2 2013 | $123,000 | – | 11,905 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |